Scientists have co-developed the world’s first product-ready, lab-produced, recombinant snakebite antivenom that protects ...
From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international ...
The EVERY Co has urged a court in Wisconsin to toss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents.
Patients with stroke who receive intra-arterial thrombolysis after thrombectomy are more likely to achieve superior 90-day ...
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics has just made one of the boldest moves in its history, a reinvention that trades long biotech timelines for immediate impact.
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics (NASDAQ:ENTO) has just made one of the boldest moves in its history, a reinvention that trades long biotech timelines for imme ...
Global Location Strategies (GLS), one of the world's leading corporate site selection firms, today unveiled its 2026 Best Places for Pharmaceutical Manufacturing Insights Report. The report identifies ...
Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...
Libtayo® (cemiplimab for injection) Now Reimbursed in Québec for Advanced Non-Small Cell Lung Cancer
TORONTO, Oct. 30, 2025 /CNW/ - Regeneron Canada Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by Régie de l'assurance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback